RANGAP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data revealed that RanGAP1 knockdown may enhance IM efficacy by inducing BCR-ABL accumulation in the nucleus and that RanGAP1 plays a regulatory role in BCR-ABL transportation and IM efficacy to determine the fate of CML cells.